?????????? ????????????: Talking transfer RNA for cancer and the biotech ecosystem for startups with Cloverleaf Bio's Austin Draycott. #AlignSummit24 Full video: https://lnkd.in/g8a5pag5 BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
Cloverleaf Bio
生物技术研究
New Haven，CT 427 位关注者
Cloverleaf is developing a new class of RNA therapeutics to revolutionize cancer therapy.
关于我们
Cloverleaf is developing a new class of RNA therapeutics to revolutionize cancer therapy.
- 网站
-
https://cloverleafbio.com/
Cloverleaf Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- New Haven，CT
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
获取路线
US，CT，New Haven，06510
Cloverleaf Bio员工
动态
-
We are excited to announce?Cloverleaf Bio will be participating at MassBio 2024 Align Summit with insights by McKinsey & Company and Locust Walk. If you would like to hear our presentation, please register here: https://lnkd.in/euynZvkA #AlignSummit24 #AlignSummit #AIDrugDiscovery
-
MassBio's Align Summit on April 25 at the Royal Sonesta Boston is a partnering event for funders and early-stage companies. This year will focus on artificial intelligence and machine learning in drug discovery and development with insights from our partners Locust Walk and McKinsey & Company. Align Summit helps create meaningful collaborations and investments. Hear more than 50 presentations on two curated tracks -- seed to Series A biotech companies and emerging companies focused on AI/ML R&D --?along with all day partnering opportunities through our powerful mobile app. Secure your spot today and join us at Align Summit 2024:? https://lnkd.in/ezhrkF8B Presenting companies include: 3T Biosciences | AI Proteins | Aitia | ArrePath | Atomic AI | AXONIS Therapeutics | BigHat Biosciences | Biolojic Design, Ltd. | BioSymetrics | Cell BioEngines, Inc | Cellarity | Cellbricks | Cha Therapeutics | Cloverleaf Bio | Cura Therapeutics Inc. | DoriNano | Edity Therapeutics | Ensem Therapeutics | Enveda Biosciences | Faeth Therapeutics | Iktos | Ilios Therapeutics | ImmunoChem Therapeutics, LLC | Javelin Biotech | Lime Therapeutics | Manifold Bio | Modulari-T Bio | Myrobalan Therapeutics | Novasenta | Orion Therapeutics, Inc. | Osmol Therapeutics, Inc. | pacDNA Inc. | Paradox Immunotherapeutics | Phenomic | Pragma Bio | PrecisionLife | Profluent Bio | ProteinQure | QurCan Therapeutics Inc. | RADBIO | REKUPERA BIOTECH Corp | ReviR Therapeutics | Rezo Therapeutics | Seragene Therapeutics | Superluminal Medicines, Inc. | TATUM bioscience | Tectonic Therapeutic | TenSixty Biosciences | TheraLode, a spinoff of UNandUP | UbiquiTx Inc | VeraMorph | VerImmune Inc
-
Congratulations Austin Draycott!
Introducing inaugural 2024 cohort of BrightEdge Entrepreneurs (BEE) Program made possible by WoodNext Foundation.?The BEE cohort will embark on a comprehensive 10-month curriculum combined with mentorship designed to advance early-career cancer researcher technical expertise and propel commercial ventures. ? These "Entrepreneurs" were selected based on alignment with American Cancer Society mission and BrightEdge - American Cancer Society investment focus areas across innovative biomedical products, prevention/screening, improving patient therapy response, R&D infrastructure, and reducing health disparities and patient burden.?#Entrepreneurship #Innovation #CancerResearch #StartUps #HealthTech #HealthEquity ? ?? Congrats to Andrew Y. Koh, M.D. Phuong Jean Pham, Austin Draycott,, Elliot Androphy, Eve McDavid, Onyinye Balogun, MD MS, Traci Lyons, Kate Caves, Ashley M. Fuller, PhD, Laura Hsieh, PhD!
-
-
Happy to have you onboard!
In Vivo Consultant with >28 years in the biotech field. Let's work together to test your novel therapeutics!
I’m happy to share that I’m starting a new position as In Vivo Consultant at Cloverleaf Bio!
此处无法显示此内容
在领英 APP 中访问此内容等
-
Super grateful to be named to the Forbes 30 Under 30 Healthcare class of 2024! I'm thrilled to be listed alongside such incredible young innovators, scientists, and entrepreneurs. We founded Cloverleaf Bio to bring our novel tRNA-based therapeutics to patients without viable options for therapy. Building Cloverleaf from a scientific discovery into a growing therapeutic platform company has been an amazing journey so far. I feel exceptionally fortunate to have such inspiring co-founders: Wendy Gilbert, whose mentorship and and scientific acumen has been essential for our success and Austin Draycott, one of the most passionate, committed, and visionary innovators I have ever met. Thank you so much to my family, friends, mentors, and everyone else in our corner for your support! https://lnkd.in/g6MG6MEk https://cloverleafbio.com/ #forbes30under30
-
-
Some long overdue good news: We are thrilled to announce Cloverleaf Bio is a winner of the Nucleate + Eli Lilly Genetic Medicine Grand Challenge! This award provides $100K in non-dilutive grant funding that will support Cloverleaf's development of tRNA therapeutics. Congratulations to all of the competing teams, we had a great time meeting you all and hearing about the innovations you're developing in genetic medicine! A big thank you to our incredible team - Austin Draycott, Cole Lewis, and Wendy Gilbert. And of course, thank you to Nucleate and Eli Lilly and Company for providing this opportunity!
-